comprehensive -WSS

comprehensive

author：knowledge 2025-09-27 19:21:23 - browse：66895

A doctor climbs up a red ladder to a vine shaped like a DNA — biotech coverage from STAT — Adobe

Every morning, Victoria Rasberry gets up before 6 a.m., walks to the bedroom down the hall, and helps her 8-year-old daughter Addi slide into a set of contraptions that squeeze and suck out the thick mucus constantly threatening to choke her airways closed. She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures. At some point, Rasberry’s five other children will wake up and start to get ready for school, including her youngest, Oliver. At 3-and-a-half years old, he’s a typical toddler — always running and giggling and getting into things. You would never know that he and Addi were born with the same mutation lurking in their DNA, a genetic glitch that causes a fatal neurodegenerative disease called metachromatic leukodystrophy, or MLD.

“When Addi was this age she had lost the ability to speak and was already using a ventilator to sleep at night,” Rasberry said. “It’s amazing to see how well Ollie is doing in comparison. And it’s all because of the gene therapy.”

Three years ago, when Ollie was just 6 months old, he and Victoria traveled from their home in Texas to Milan, to receive a gene therapy treatment that adds a healthy version of the defective gene into patients’ own stem cells. At the time, traveling abroad for the therapy, which is manufactured by Orchard Therapeutics and was approved in Europe in 2021, was the only option for families stricken by MLD. But soon it will be available in the U.S., too.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： EpiPen alternative approval delay highlights citizen petition issue

focus

hotspot

WSS

Lasker Awards 2023: Winners in biomedical research

It's been 20 years since Dolly the sheep. Where's my clone?

Why are Kaiser Permanente staff considering a strike?

Hearing on Medicare drug price negotiation gets unusually heated

CDC's new outbreak response network to include Northeastern

Why are Kaiser Permanente staff considering a strike?

explore

comprehensive

hotspot

Heart attack and stroke risk calculators need revising

Biotech lab space demand falls sharply

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How Vertex's cystic fibrosis drug is changing patients' lives

The cancer drug shortage isn’t new — and neither are the solutions

Superbugs, antibiotic resistance get scrutiny in congress

Medicare details structure of new drug price negotiation program

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

focus

Readout LOUD podcast: possible new ALS drug, artificial wombs

Why are Kaiser Permanente staff considering a strike?

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Thermo Fisher plant for manufacturing gene therapies to expand

Companies helping big Covid

Women's World Cup brings attention to abuse in soccer

focus

hotspot

focus

explore